{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T13:04:14Z","timestamp":1783775054263,"version":"3.55.0"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T00:00:00Z","timestamp":1575849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T00:00:00Z","timestamp":1575849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurocrit Care"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s12028-019-00889-z","type":"journal-article","created":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T21:02:36Z","timestamp":1575925356000},"page":"582-586","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Resource Allocation: Stable Patients Remain Stable 12\u201324\u00a0h Post-tPA"],"prefix":"10.1007","volume":"33","author":[{"given":"Sheena","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandria","family":"Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2385-5074","authenticated-orcid":false,"given":"Elisabeth B.","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,9]]},"reference":[{"key":"889_CR1","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1056\/NEJM199512143332401","volume":"333","author":"National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group","year":"1995","unstructured":"National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581\u20138.","journal-title":"N Engl J Med"},{"key":"889_CR2","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1056\/NEJMoa1414905","volume":"372","author":"M Goyal","year":"2015","unstructured":"Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, Thornton J, ESCAPE Trial Investigators, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. NEJM. 2015;372:1019\u201330.","journal-title":"NEJM."},{"key":"889_CR3","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1161\/01.STR.0000064841.47697.22","volume":"34","author":"HP Adams Jr","year":"2003","unstructured":"Adams HP Jr, Adams RJ, Brott T, del Zoppo GJ, Furlan A, Goldstein LB, et al. Guidelines for the early management of patients with ischemic stroke: a scientific statement from the Stroke Council of the Am Stroke Association. Stroke. 2003;34:1056\u201383.","journal-title":"Stroke"},{"issue":"2","key":"889_CR4","doi-asserted-by":"publisher","first-page":"e88652","DOI":"10.1371\/journal.pone.0088652","volume":"9","author":"R Faigle","year":"2014","unstructured":"Faigle R, Sharrief A, Marsh EB, Llinas RH, Urrutia VC. Predictors of critical care needs after IV thrombolysis for acute ischemic stroke. PLoS ONE. 2014;9(2):e88652.","journal-title":"PLoS ONE"},{"issue":"6","key":"889_CR5","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1161\/STROKEAHA.118.021398","volume":"49","author":"A Chang","year":"2018","unstructured":"Chang A, Llinas EJ, Chen K, Llinas RH, Marsh EB. Shorter intensive care unit stays?\u00a0The majority of post-intravenous tpa (tissue-type plasminogen activator) symptomatic hemorrhages occur within 12\u00a0h of treatment. Stroke. 2018;49(6):1521\u20134.","journal-title":"Stroke"},{"issue":"8","key":"889_CR6","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1161\/01.STR.30.8.1534","volume":"30","author":"SE Kasner","year":"1999","unstructured":"Kasner SE, Chalela JA, Luciano JM, et al. Reliability and validity of estimating the NIHS stroke scale score from medical records. Stroke. 1999;30(8):1534\u20137.","journal-title":"Stroke"},{"issue":"9","key":"889_CR7","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1001\/jama.283.9.1145","volume":"283","author":"GW Albers","year":"2000","unstructured":"Albers GW, Bates VE, Clark WM, Bell R, Verro P, Hamilton SA. Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study. JAMA. 2000;283(9):1145\u201350.","journal-title":"JAMA"}],"container-title":["Neurocritical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-019-00889-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12028-019-00889-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-019-00889-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T04:28:20Z","timestamp":1744172900000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12028-019-00889-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,9]]},"references-count":7,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["889"],"URL":"https:\/\/doi.org\/10.1007\/s12028-019-00889-z","relation":{},"ISSN":["1541-6933","1556-0961"],"issn-type":[{"value":"1541-6933","type":"print"},{"value":"1556-0961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,9]]},"assertion":[{"value":"9 December 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Sources of funding"}},{"value":"Dr. Marsh receives funding from the American Heart Association and is on the editorial board for Stroke. The authors otherwise have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}